HOME › DRUGS › FIDANACOGENE ELAPARVOVEC
ACTIVE SUBSTANCE / INN

FIDANACOGENE ELAPARVOVEC

Brand name(s): Beqvez (previously Durveqtix)
EMA LISTED
WITHDRAWN
Hemophilia B
ACTIVE SUBSTANCE
Fidanacogene Elaparvovec
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Beqvez (previously Durveqtix)Pfizer Europe MA EEIGWithdrawn24/07/2024Hemophilia B

FULL INTELLIGENCE ON FIDANACOGENE ELAPARVOVEC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →